Literature DB >> 23890478

Mutational analysis of ACTN4, encoding α-actinin 4, in patients with focal segmental glomerulosclerosis using HRM method.

M Safaříková1, J Reiterová, H Safránková, J Stekrová, A Zidková, L Obeidová, M Kohoutová, V Tesař.   

Abstract

α-Actinin 4, encoded by ACTN4, is an F-actin crosslinking protein which belongs to the spectrin gene superfamily. It has a head-to-tail homodimer structure with three main domains. Mutations in ACTN4 are associated with idiopathic nephrotic syndrome (NS). However, until today only a few mutations have been described in this gene. We used genomic DNA of 48 patients with focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) to screen for ACTN4 mutations by high-resolution melting analysis (HRM). Suspect samples were sequenced and compared with healthy controls. To investigate the prevalence and possible effect of some substitutions found in FSGS/MCD patients we also looked for these changes in patients with IgA nephropathy (IgAN) and membranous glomerulonephritis (MGN). We found 20 exonic and intronic substitutions in the group of 48 Czech patients. The substitution 2242A>G (p.Asn748Asp) is a candidate mutation which was identified in one patient but not in any of the 200 healthy controls. Exon 19 seems to be a variable region due to the amount of revealed polymorphisms. In this region we also found three unreported substitutions in IgAN patients, c.2351C>T (p.Ala784Val), c.2378G>A (p.Cys793Tyr) and c.2393G>A (p.Gly798Asp). These substitutions were not found in any tested healthy controls. To conclude, the ACTN4 mutations are not a frequent cause of FSGS/MCD in Czech adult patients. One new ACTN4 mutation has been identified.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23890478

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  3 in total

1.  Developing and Evaluating the HRM Technique for Identifying Cytochrome P450 2D6 Polymorphisms.

Authors:  Hsiu-Chin Lu; Ya-Sian Chang; Chun-Chi Chang; Ching-Hsiung Lin; Jan-Gowth Chang
Journal:  J Clin Lab Anal       Date:  2014-05-05       Impact factor: 2.352

2.  Identification of a Novel ACTN4 Gene Mutation Which Is Resistant to Primary Nephrotic Syndrome Therapy.

Authors:  Lingzhang Meng; Shan Cao; Na Lin; Jingjie Zhao; Xulong Cai; Yonghua Liang; Ken Huang; Mali Lin; Xiajing Chen; Dongming Li; Junli Wang; Lijuan Yang; Aibo Wei; Genliang Li; Qingmei Lu; Yuxiu Guo; Qiuju Wei; Junhua Tan; Meiying Huang; Yuming Huang; Jie Wang; Yunguang Liu
Journal:  Biomed Res Int       Date:  2019-12-14       Impact factor: 3.411

3.  Case report and literature review: A de novo pathogenic missense variant in ACTN4 gene caused rapid progression to end-stage renal disease.

Authors:  Zhechi He; Ke Wu; Wenqing Xie; Jianghua Chen
Journal:  Front Pediatr       Date:  2022-08-25       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.